Pharmaceuticals, Biotechnology and Life Sciences
The UK has approved Pfizer’s COVID-19 vaccine on Wednesday, becoming the first country in the world to do so, going ahead of the United States and the EU countries, who expect to bring the decisions on authorization in December.
UK government has now secured 7 million doses of mRNA-1273 Agreement reflects Moderna’s commitment to make its vaccine available in…
Pfizer’s and Biontech’s vaccine candidate for COVID-19 has met all the study’s primary efficacy endpoints.
Pfizer says its vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis
UbiVac has announced working with BMS on Phase Ib study to combine UbiVac’s DRibble® Platform Vaccine, DPV-001 with anti-OX40 (BMS-986178) and Opdivo (nivolumab) to test hypothesis that this combination will augment anticancer immunity in advanced triple negative breast cancer.
CordenPharma has announced Tuesday its extended agreement with Moderna in its supply of lipids to support the development of Coronavirus Vaccine.
Needle-free Vaxxas HD-MAP can enhance routine vaccination with potential to revolutionize vaccination in pandemic response; produce more patient-doses from limited…
Moderna said that after two doses all participants evaluated to date across the 25 µg and 100 µg dose cohorts…
Leinco Technologies and Vanderbilt University Medical Center (VUMC) have agreed to scale up production of its most promising antibodies for development of a rapid, point of care COVID-19 diagnostic test.
Abivax said Thursday that ABX464 inhibits replication of SARS-CoV-2 in an in vitro reconstituted human respiratory epithelium model, as assessed by Transepithelial electrical resistance and RTqPCR.